Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-28T01:45:47.041Z Has data issue: false hasContentIssue false
  • English
  • Français

Cyclosporin A: antiparasite drug, modulator of the host-parasite relationship and immunosuppressant

Published online by Cambridge University Press:  06 April 2009

L. H. Chappell  and
J. M. Wastling
L. H. Chappell
Affiliation:
Department of Zoology, University of Aberdeen, Tillydrone Avenue, Aberdeen, AB9 2TN, Scotland
J. M. Wastling
Affiliation:
Moredun Research Institute, 408 Gilmerton Road, Edinburgh, EH17 7JH, Scotland
Get access Rights & Permissions [Opens in a new window]

Summary

Cyclosporin A (CsA), a cyclic undecapeptide with powerful properties of immunosuppression, acts on parasitic infections in laboratory animals in various ways. The outcome of drug administration in vivo varies with timing of treatment relative to infection, route of administration, dose and number of treatments applied. CsA is clearly antiparasitic against malaria, schistosomes, adult tapeworms, metacestodes and filarial nematodes. By contrast, it acts as an immunomodulator against trypanosomes and Giardia, by exacerbating infection; in the case ofLeishmania spp. the drug acts variously. In some other infections CsA acts both as an antiparasite drug and as an immunosuppressant (Toxoplasma, avian coccidiosis and gastrointestinal nematodes).

Type
Research Article
Information
Parasitology , Volume 105 , Issue S1: Chemotherapy and the immune system , January 1992 , pp. S25 - S40
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Adinolfi, L. E. & Bonventre, P. F. (1990). Cyclosporin A treatment converts Leishmania donovani-infected C57BL/10 (curing) mice to a non-curing phenotype. Infection & Immunity 58, 3151–3.CrossRefGoogle Scholar
Aldridge, R. D. & Thomson, A. W. (1986). Factors influencing the enhancement of delayed-type hypersensitivity to ovalbumin by cyclosporin A in the guinea pig: possible role of suppressor cells. International Archives of Allergy and Applied Immunology 81, 17–23.CrossRefGoogle ScholarPubMed
Amiri, P., Locksley, R. M., Parslow, T. G., Sadick, M., Rector, E., Ritter, D. & Mckerrow, J. H. (1992). Tumour necrosis factor αrestores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 356, 604–7.CrossRefGoogle ScholarPubMed
Behforouz, N., Wenger, C. D. & Mathison, B. A. (1986). Prophylactic treatment of Balb/C mice with cyclosporin A and its analog B–5–49 enhances resistance to Leishmania major. Journal of Immunology 136, 3067–75.CrossRefGoogle ScholarPubMed
Belosevic, M., Faubert, G. M. & Maclean, J. D. (1986). The effects of cyclosporin A on the course of infection with Giardia muris in mice. American Journal of Tropical Medicine and Hygiene 35, 496–500.CrossRefGoogle ScholarPubMed
Bogdan, C., Streck, H., Rollinghoff, M. & Solbach, W. (1989). Cyclospirin A enhances elimination of intracellular L. major parasites by murine macrophages. Clinical and Experimental Immunology 75, 141–6.Google Scholar
Bolas-Fernandez, F., Grencis, R. K. & Wakelin, D. (1988). Cyclosporin A and Trichinella spiralis: anthelmintic effects in immunosuppressed mice. Parasite Immunology 10, 111–16.CrossRefGoogle ScholarPubMed
Bolas-Fernandez, F., Grencis, R. K. & Wakelin, D. (1989). Protective effect of cyclosporin A upon muscular invasion by Trichinella spiralis. In Trichinellosis. Proceedings of the Seventh International Conference on Trichinellosis. (ed.Tanner, C. E., Martinez-Fernandez, A. R. & Bolas-Fernandez, F.) pp. 464–70. Alicante, Spain, Graficas Diaz.Google Scholar
Borel, J. F. (1989a). The cyclosporins. Transplantation Proceedings 21, 810–15.Google ScholarPubMed
Borel, J. F. (1989b). Pharmacology of cyclosporine (Sandimmune) IV. Pharmacological properties in vivo. Pharmacological Reviews 41, 259–371.Google Scholar
Boullon, F., Sinagra, A., Riarte, A., Lauricella, M., Barra, J., Besanson, M., Lejour, C., Blanco, Lopez O., Favaloro, R. & Segura, E. L. (1988). Experimental cardiac transplantation and chronic Chagas' disease in dogs. Transplantation Proceedings 20, Suppl. 1yes, 432–7.Google ScholarPubMed
Bout, D., Deslee, D. & Capron, A. (1984). Protection against schistosomiasis produced by cyclosporin A. American Journal of Tropical Medicine and Hygiene 33, 185–6.CrossRefGoogle ScholarPubMed
Bout, D., Deslee, D. & Capron, A. (1986). Antischistosomal effect of cyclosporin A: cure and prevention of mouse and rat Schistosomiasis mansoni. Infection and Immunity 52, 823–7.CrossRefGoogle ScholarPubMed
Bout, D., Haque, A. & Capron, A. (1984). Filaricidal effects of cyclosporin-A against Dipetalonema viteae in Mastomys natalensis. Transactions of the Royal Society of Tropical Medicine and Hygiene 78, 670–1.CrossRefGoogle ScholarPubMed
Bouteille, B., Darde, M. L. & Pestre-Alexandre, M. (1988). Action des médicaments testes en milieu acellulaire et chez Ia souris infecteé par Trypanosoma brucei brucei. Bulletin de la Societé de Pathologie et Exotic Filiales 81, 533–42.Google Scholar
Brannan, L. R., Chappell, L. H., Woo, J. & Thomson, A. W. (1989). Anti-schistosomal activity of cyclosporin A: studies on murine spleen cells and the influence of a cyclosporin antagonist on resistance to infection. Immunology 67, 382–7.Google ScholarPubMed
Bresson-Hadni, S., Pranza, A., Lenys, D., Miguet, J. P., Paintaud, G., Monnet, E., Vuitton, D., Mantion, G. & Gillet, M. (1990). Treatment of human alveolar echinococcosis (AE) by liver transplantation: indications, clinical and serological follow up. Bulletin de la Societé Francaise de Parasitologie 8 (Suppl. 1yes): 418.Google Scholar
Bueding, E. & Hawkins, J. (1983). Globinases and the antischistosomal action of cyclosporin A. In Molecular Parasitology (ed. August, J. T.) London, Academic Press. pp. 283–8.Google Scholar
Bueding, E., Hawkins, J. & Cha, Y.-N. (1981). Antischistosomal effects of cyclosporin A. Agents and Actions 11, 380–3.CrossRefGoogle ScholarPubMed
Cabaj, W. & Stefanski, W. (1990). The effect of cyclosporin A on the course of infection by Trichinella pseudospiralis or Nematospiroides dubius on C3H strain of mice. Bulletin de la Societé Francaise de Parasitologie 8 (suppl. 2yes), 1077.Google Scholar
Chappell, L. H. & Thomson, A. W. (1988). Studies on the action of cyclosporin A against Schistosoma mansoni and other parasitic infections. Transplantation Proceedings 20 (suppl. 2yes), 291–7.Google ScholarPubMed
Chappell, L. H., Thomson, A. W., Barker, G. C. & Smith, S. W. G. (1987). Dosage, timing, and route of administration of cyclosporin A and nonimmunosuppressive derivatives of dihydrocyclosporin A and cyclosporin C against Schistosoma mansoni in vivo and in vitro. Antimicrobial Agents and Chemotherapy 31, 1567–71.CrossRefGoogle ScholarPubMed
Chappell, L. H., Wastling, J. M. & Hurd, H. (1989). Action of cyclosporin A on the tapeworms Hymenolepis microstoma, H. diminuta and Mesocestoides corti in vivo. Parasitology 98, 291–9.CrossRefGoogle ScholarPubMed
Clegg, J. A. (1965). In vitro cultivation of Schistosoma mansoni. Experimental Parasitology 16, 133–47.CrossRefGoogle ScholarPubMed
Clipstone, N. A. & Crabtree, G. R. (1992). Identification of calcineurin as a key signalling component in T-lymphocyte activation. Nature 357, 695–7.CrossRefGoogle Scholar
Cole, G. A., Nickell, S. P., Mokhtarian, F. & Scheibel, L. W. (1983). Effects of cyclosporine on experimental infections. Transplantation Proceedings 15, 3013–18.Google Scholar
Cruz, F. S. & Alex, A. (1990). Effect of azathioprine and ciclosporin A in T. cruzi infected mice. Bulletin de la Societé Francaise de Parasitologie 8 (suppl. 2yes), 1034.Google Scholar
De Franco, A. L. (1991). Irnmunosuppressants at work. Nature 352, 754–5.CrossRefGoogle ScholarPubMed
Dyer, M., Volpe, F., Delves, C. J., Somia, N., Barns, F. & Scaife, J. G. (1992). Cloning and sequence of a B-tubulin cDNA from Pneumocystis carinii: possible implications for drug therapy. Molecular Microbiology 6, 991–1001.CrossRefGoogle Scholar
Eichhorn, M., Magnuson, N. S., Reeves, R., Williams, R. O. & Dobbelaere, D. A. E. (1990). IL-2 can enhance the cyclosporin A-mediated inhibition of Theileria parva-infected T cell proliferation. Journal of Immunology 144, 691–8.CrossRefGoogle ScholarPubMed
Eldaw, A., Sequeira, R. P. & Eldirdiri, A. B. (1989). A preliminary observation on in vitro inhibitory effect of cyclosporin A upon growth of Leishmania tropica promastigotes. Journal of the Egyptian Society of Parasitology 19, 301–3.Google ScholarPubMed
Foxwell, B. M. J., Frazer, G., Winters, M., Hiestand, P., Wenger, H. & Ryffel, B. (1988). Identification of cyclophilin as the erythrocyte ciclosporin-binding protein. Biochimica et Biophysica Acta 938, 447–55.CrossRefGoogle ScholarPubMed
Flanagan, W. M., Corthesy, B., Bram, R. J. & Crabtree, G. R. (1991). Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352, 807.CrossRefGoogle ScholarPubMed
Franklin, R. M., Brun, R. & Grieder, A. (1986). Microscopic and flow cytophotometric analysis of parasitemia in cultures of Plasmodium falciparum vitally stained with Hoechst 33342 – application to studies of antimalarial agents. Zeitschrift für Parasitenkunde 72, 201–12.CrossRefGoogle ScholarPubMed
Girardin, P. & Brossard, M. (1989). Effects of cyclosporin A on humoral immunity to ticks and on cutaneous immediate and delayed hypersensitivity reactions to Ixodes ricinus L. salivary-gland antigens in re-infected rabbits. Parasitology Research 75, 657–62.CrossRefGoogle Scholar
Grau, G. E., Giudice, D. & Lambert, P. H. (1987). Host immune response and pathological expression in malaria: possible implications for malaria vaccines. Parasitology 94 (supplyes), S130–7.CrossRefGoogle ScholarPubMed
Grau, G. E., Gretner, D. & Lambert, P.-H. (1987). Prevention of murine cerebral malaria by low-dose cyclosporin A. Immunology 61, 521–5.Google ScholarPubMed
Grencis, R. K., Fernandez-Bolas, F. & Wakelin, D. (1989). Trichinella spiralis and cyclosporin A: suppression of cell mediated immunity in relation to anti-parasitic effects. In TrichinellosisProceedings of the Seventh International Conference on Trichinellosis. (ed. Tanner, C. E., Martinez-Fernandez, A. R. & Bolas-Fernandez, F.) pp. 165–70. Alicante, Spain, Graficas Diaz.Google Scholar
Hashiguchi, Y. & Okamura, Y. (1988). The effect of cyclosporin A on the course of Paragonimus miyazakii infection in rats. Journal of Helminthology 62, 251–6.CrossRefGoogle ScholarPubMed
Hashiguchi, Y. & Okamura, Y. (1989). Further studies on the effect of cyclosporin A on the course of Paragonimus infection in rats. Journal of Helminthology 63, 328–32.CrossRefGoogle ScholarPubMed
Hoeprich, P. D. & Merry, J. M. (1987). Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis. Diagnostic Microbiology and Infectious Diseases 6, 287–92.CrossRefGoogle ScholarPubMed
Hofflin, J. M., Conely, F. K. & Remington, J. S. (1987). Murine model of intracerebral toxoplasmosis. Journal of Infectious Diseases 155, 550–7.CrossRefGoogle ScholarPubMed
Hofflin, J. M., Mccabe, R. E. & Remington, J. S. (1984). In vivo and in vitro effect of cyclosporin A on Toxoplasma gondii. Federation Proceedings 43, 1770.Google Scholar
Hopkins, C. A. (1980). Immunity and Hymenolepis diminuta. In Biology of the Tapeworm Hymenolepis diminuta (ed. Arai, H. P.), pp. 551–614. London, Academic Press.CrossRefGoogle Scholar
Hopkins, C. A., Subramanian, G. & Stallard, H. (1972a). The development of Hymenolepis diminuta in primary and secondary infections in mice. Parasitology 64, 401–12.CrossRefGoogle ScholarPubMed
Hopkins, C. A., Subramanian, G. & Stallard, H. (1972b). The effect of immunosuppressants on the development of Hymenolepis diminuta in mice. Parasitology 65, 111–20.CrossRefGoogle ScholarPubMed
House, H. V. & Dean, J. H. (1988). Trypanosoma musculi: characterization of the T-lymphocyte dependency of immunity by selective immunomodulation of the mouse, Mus musculus. Experimental Parasitology 67, 104–15.CrossRefGoogle ScholarPubMed
Hughes, W. T. & Smith, B. (1982). Provocation of infection due to Pneumocystis carinii by cyclosporin A. Journal of Infectious Diseases 145, 767.CrossRefGoogle ScholarPubMed
Iida, T., Nozaki, Y., Fukuyama, K. & Epstein, W. L. (1991). An improved noninfectious murine skin model of organized granulomatous inflammation. Experientia 47 273–7.CrossRefGoogle ScholarPubMed
Kallen, J., Spitzfaden, C., Zurini, M. G. M., Wider, H., Wutrich, K. & Walkinshaw, M. D. (1991). Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy. Nature 353, 276–9.CrossRefGoogle ScholarPubMed
Kierszenbaum, F., Gottlieb, C. A. & Budzko, D. B. (1983). Exacerbation of Trypanosoma cruzi infection in mice treated with the immunoregulatory agent cyclosporin A. Tropenmedizin und Parasitologie 34, 4–6.Google ScholarPubMed
Kirkland, T. H. & Fierer, J. (1983). Cyclosporin A inhibits Coccidioides immitis in vitro and in vivo. Antimicrobial Agents and Chemotherapy 24, 921–4.CrossRefGoogle ScholarPubMed
Koletsky, A. J., Harding, M. W. & Handschumacher, R. E. (1986). Cyclophilin: distribution and variant properties in normal and neoplastic tissues. Journal of Immunology 137, 1054–9.CrossRefGoogle ScholarPubMed
Kogut, M. H. & Eirmann, L. (1991). The effect of cyclosporin A on the development of Eimeria in a non-specific host. International Journal of Parasitology 21, 979–87.CrossRefGoogle Scholar
Leiro, J., Santamarina, M. T., Sernandez, L., Sanmartin, M. L. & Ubeira, F. M. (1989). The effect of cyclosporine A on murine trichinellosis. Parasitology Research 75, 330–2.CrossRefGoogle ScholarPubMed
Liance, M., Bresson-Hadni, S., Vuitton, D. A., Lenys, D., Carbillet, J. P. & Houin, R. (1992). Effects of cyclosporin A on the course of murine alveolar echinococcosis and on specific cellular and humoral immune responses against Echinococcus multilocularis. International Journal for Parasitology 22, 23–8.CrossRefGoogle ScholarPubMed
Liance, M., Vuitton, D., Bresson-Hadni, S., Deniau, M. & Houin, R. (1990). Cyclosporin A (CsA) and murine alveolar echinococcosis. Bulletin de la Societé Francaise de Parasitologie 8 (suppl. 2yes), 1051.Google Scholar
Lightowlers, M. W., Haralambous, A. & Rickard, M. D. (1989). Amino acid sequence homology between cyclophilin and a cDNA-cloned antigen of Echinococcus granulosus. Molecular and Biochemical Parasitology 36, 287–90.CrossRefGoogle Scholar
Lillehoj, H. S. (1987). Effects of immunosuppression on avian coccidiosis: cyclosporin A but not humoral bursectomy abrogates host protective immunity. Infection and Immunity 55, 1616–21.CrossRefGoogle Scholar
Mccabe, R. E., Luft, B. J. & Remington, J. S. (1986). The effects of cyclosporine on Toxoplasma gondii in vivo and in vitro. Transplantation 41, 611–15.CrossRefGoogle ScholarPubMed
Mccabe, R. E., Meagher, S. & Mullins, B. (1991). Gamma interferon suppresses acute and chronic Trypanosoma cruzi infection in cyclosporin-treated mice. Infection and Immunity 59, 1633–8.CrossRefGoogle ScholarPubMed
Mccabe, R. E., Remington, J. S. & Araujo, F. G. (1985). In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene 34, 861–5.CrossRefGoogle ScholarPubMed
Mckeon, F. (1991). When worlds collide: immunosuppressants meet protein phosphatases. Cell 66, 823–6.CrossRefGoogle ScholarPubMed
Mack, D. G. & Mcleod, R. (1984). New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A. Antimicrobial Agents and Chemotherapy 26, 26–30.CrossRefGoogle Scholar
Matsumoto, Y., Perry, G., Scheibel, L. W. & Aikawa, M. (1987). Role of calmodulin in Plasmodium falciparum: implications for erythrocyte invasion by the merozoite. European Journal of Cell Biology 45, 36–43.Google ScholarPubMed
Mazinque, C., Cottrez-Detoeuf, F., Louis, J., Kweider, M., Auriault, C. & Capron, A. (1989). In vitro and in vivo effects of interleukin 2 on the protozoan parasite leishmania. European Journal of Immunology 19, 487–91.CrossRefGoogle Scholar
Metzger, J. M. & Peterson, L. B. (1988). Cyclosporin A enhances the pulmonary granuloma response induced by Schistosoma mansoni eggs. Immunopharmacology 15, 103–15.CrossRefGoogle ScholarPubMed
Miller, T. E., Findon, G. & Cawley, S. (1987). Cellular basis of host defence in pyelonephritis. III. Deletion of individual components. British Journal of Experimental Pathology 68, 377–8.Google ScholarPubMed
Mody, C. H., Toews, G. B. & Lipscomb, M. F. (1988). Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model. Infection and Immunity 56, 7–12.CrossRefGoogle ScholarPubMed
Munro, G. H., Brannan, L. R., Chappell, L. H., Thomson, A. W. & Mclaren, D. J. (1991). The larvicidal activity of cyclosporin A against Schistosoma mansoni in mice. Parasitology 102, 57–63.CrossRefGoogle ScholarPubMed
Munro, G. H. & Mclaren, D. J. (1990a). Toxicity of cyclosporin A (CsA) against developmental stages of Schistosoma mansoni in mice. Parasitology 100, 29–43.CrossRefGoogle ScholarPubMed
Munro, G. H. & Mclaren, D. J. (1990b). Schistosoma mansoni: morphology and ultrastructure of adult worms recovered from cyclosporin A-treated mice. Parasitology 100, 19–28.CrossRefGoogle ScholarPubMed
Murphy, J. R., Baqar, S., Baker, R. H., Roberts, E., Nickell, S. P. & Cole, G. A. (1988). Stage-selective inhibition of rodent malaria by cyclosporine. Antimicrobial Agents and Chemotherapy 32, 462–6.CrossRefGoogle ScholarPubMed
Nickell, S. P., Scheibel, L. W. & Cole, G. A. (1982). Inhibition by cyclosporin A of rodent malaria in vitro. Infection and Immunity 37, 1093–100.CrossRefGoogle ScholarPubMed
Nilsson, L.-A., Linblad, R., Olling, S. & Ouchterlony, O. (1985). The effect of cyclosporin A on the course of murine infection by Schistosoma mansoni. Parasite Immunology 7, 17–27.CrossRefGoogle ScholarPubMed
Nogami, M., Matsunobu, S., Okudaira, H., Miyamoto, T., Shiga, J., Ito, M. & Kasuya, S. (1990). Experimental pulmonary eosinophilia in mice by Ascaris suum extract. American Review of Respiratory Diseases 141, 1289–95.CrossRefGoogle ScholarPubMed
Nüssler, A. K. & Thomson, A. W. (1992). Immunomodulatory agents in the laboratory and the clinic. Parasitology 105, S5–S23.CrossRefGoogle Scholar
O'Keefe, S. J., Tamura, J., Kincaid, R. L., Tocci, M. J. & O'Neill, A. (1992). FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357, 692–4.CrossRefGoogle ScholarPubMed
Olivier, M., Proulx, C. & Tanner, C. E. (1989). Importance of lymphokines in the control of multiplication and dispersion of Leishmania donovani within liver macrophages of resistant and susceptible mice. Journal of Parasitology 75, 720–7.CrossRefGoogle ScholarPubMed
Olivier, M. & Tanner, C. E. (1989). The effect of cyclosporin A in murine visceral leishmaniasis. Tropical Medicine and Parasitology 40, 32–8.Google ScholarPubMed
Perfect, J. R. & Durack, D. T. (1985). Effects of cyclosporine in experimental cryptococcal meningitis. Infection and Immunity 50, 22–6.CrossRefGoogle ScholarPubMed
Phillips, S. M., Walker, D., Abdel-Hafez, S. K., Linette, G. P., Doughty, B. L., Perrin, P. J. & Fathelbab, N. (1987). The immune response to Schistosoma mansoni infections in inbred rats VI. Regulation by T cell subpopulations. Journal of Immunology 139, 2781–7.CrossRefGoogle ScholarPubMed
Pons, H. A., Adams, S. & Stadecker, M. J. (1988). Schistosoma mansoni: the basis for the antischistosomal effect of cyclosporine A. Experimental Parasitology 67, 190–8.CrossRefGoogle ScholarPubMed
Rintelen, M., Schein, E. & Ahmed, J. S. (1990). Buparvaquone but not cyclosporin A prevents Theileria annulata-infected bovine lymphoblastoid cells from stimulating uninfected lymphocytes. Tropical Medicine and Parasitology 41, 203–7.Google Scholar
Roger, M., Vigeant, P. & Viens, P. (1988). The effect of cyclosporin A on Trypanosoma musculi infection of mice. Canadian Journal of Microbiology 34, 92–4.CrossRefGoogle ScholarPubMed
Romia, S. A., Abu-Zakham, A. A., Al-Naggar, H. M., Atia, R. A. & Abu-Shady, A. F. (1990). The course of Giardia muris infection in immunocompetent and immunocompromised mice. Journal of the Egyptian Society of Parasitology 20, 721–8.Google ScholarPubMed
Rose, M. E., Hesketh, P., Grencis, R. K. & Wakelin, D. (1989). Eimeria vermiformis and E. mitis: inhibition of development in vivo by cyclosporin A. Experimental Parasitology 68, 289–96.CrossRefGoogle Scholar
Rottenburg, M. E., Cardoni, R. L., Sinagra, A., Riarte, A., Nantes, I. R., Lauricella, M. & Segura, E. L. (1991). Trypanosoma cruzi: T-cell-dependent mechanisms of resistance during chronic infection. Experimental Parasitology 73, 127–36.CrossRefGoogle Scholar
Schad, G. A. (1986). Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. Journal of Infectious Diseases 153, 178.CrossRefGoogle ScholarPubMed
Scheibel, L. W., Bueding, E., Fish, W. R. & Hawkins, J. T. (1984). Protease inhibitors and antimalarial effects. In Malaria and the Red Cell (ed. Eaton, J. W. & Brewer, G. J.). pp. 131–142. New York: Alan R. Liss, Inc.Google Scholar
Scheibel, L. W., Colombani, P. M., Hess, A. D., Aikwana, M., Atkinson, C. T. & Milhous, W. K. (1987). Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design. Proceedings of the National Academy of Science USA 84, 7310–14.CrossRefGoogle ScholarPubMed
Sher, A. (1992). Parasitizing the cytokine system. Nature 356, 565–7.CrossRefGoogle ScholarPubMed
Shirahata, T., Katsuda, K., Ohta, C. & Goto, H. (1990). Effects of cyclosporin A on susceptibility and interferon-generating capacity in mice infected with Toxoplasma gondii. Japanese Journal of Veterinary Science 52, 387–93.Google ScholarPubMed
Smith, S. W. G., Chappell, L. H., Thomson, A. W., Macgowan, A. G. & Simpson, J. G. (1988). Prophylactic and therapeutic effects of ciclosporin A in murine Schistosomiasis mansoni: studies on bisexual and unisexual infections and the hepatic inflammatory response. International Archives of Allergy and Applied Immunology 85, 174–9.CrossRefGoogle ScholarPubMed
Sobh, M. A., Moustafa, F. E., Sally, S. M., Foda, M. A., Deelder, A. M. & Ghoneim, M. A. (1989). A prospective, randomized therapeutic trial for schistosomal specific nephropathy. Kidney International 36, 904–7.CrossRefGoogle ScholarPubMed
Solbach, W., Forberg, K., Kammerer, E., Bogdan, C. & Rollinghoff, M. (1986). Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible Balb/c mice. Journal of Immunology 137, 702–7.CrossRefGoogle ScholarPubMed
Solbach, W., Forberg, K. & Rollinghoff, M. (1986). Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible Balb/c mice. Infection and Immunity 54, 909–12.CrossRefGoogle ScholarPubMed
Somasundaram, C., NG, M. L. & Sinniah, R. (1989). An in vivo study on the effect of the immunosuppressant drug cyclosporin in malaria-infected mice. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 71.CrossRefGoogle Scholar
Steiner, J. P., Dawson, T. M., Fotuhi, M., Glatt, C. E., Snowman, A. M., Cohen, M. & Snyder, S. H. (1992). High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358, 584–7.CrossRefGoogle ScholarPubMed
Suya, H., Fujioka, A., Pincelli, C., Fukuyama, K. & Epstein, W. L. (1988). Skin granuloma formation in mice immunosuppressed by cyclosporine. Journal of Investigative Dermatology 90, 430–3.CrossRefGoogle ScholarPubMed
Suzuki, Y., Orellana, N. A., Schreiber, R. D. & Remington, J. S. (1988). Interferonγ: the major mediator of resistance against Toxoplasma gondii. Science 240, 516–17.CrossRefGoogle ScholarPubMed
Thommen-Scott, K. (1981). Antimalarial activity of cyclosporin A. Agents and Actions 11, 770–3.CrossRefGoogle ScholarPubMed
Thomson, A. W. & Chappell, L. H. (1988). Immunophenotypic analysis of blood and spleen lymphocyte subsets in rats protected against schistosomiasis by cyclosporin A. Immunology Letters 17, 169–72.CrossRefGoogle ScholarPubMed
Thomson, A. W., Smith, S. W. G. & Chappell, L. H. (1986). Cyclosporin A: immune suppressant and antiparasitic agent. Parasitology Today 2, 288–90.CrossRefGoogle ScholarPubMed
Tropschug, M., Barthelmess, I. B. & Neupert, W. (1989). Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae. Nature 342, 953–5.CrossRefGoogle ScholarPubMed
Tropschug, M., Nicholson, D. W., Hartl, F.-U., Kohler, H., Pfanner, N., Wachter, E. & Neupert, W. (1988). Cyclosporin A-binding protein (cyclophilin) of Neurospora crassa. Journal of Biological Chemistry 263, 14433–40.CrossRefGoogle ScholarPubMed
Uppender, M. & Saxena, Q. B. (1990). Effect of cyclosporin-A, antimalarial drug, on lymphocyte proliferation of Balb/c mice in vitro. Indian Journal of Experimental Biology 28, 880–2.Google Scholar
Vickery, A. C. & Nayar, J. K. (1987). Brugia pahangi in nude mice: protective immunity to infective larvae is Thy l ·2+ cell dependent and cyclosporin A resistant. Journal of Helminthology 61, 19–27.CrossRefGoogle Scholar
Wastling, J. M. (1990). The action of cyclosporin A on helminth parasites. Ph.D thesis, University of Aberdeen, UK.Google Scholar
Wastling, J. M., Gerrard, D., Walker, J. & Chappell, L. H. (1990). Action of cyclosporin A on the tapeworm Hymenolepis diminuta in mice. Parasitology 101, 465–72.CrossRefGoogle ScholarPubMed
Wastling, J. M. & Chappell, L. H. (1990). Differential effects of cyclosporin A on hymenolepid tapeworms. Bulletin de la Societé Francaise de Parasitologie 8 (suppl. 2yes), 1027.Google Scholar
Wastling, J. M., Mackenzie, K. & Chappell, L. H. (1992). Effects of cyclosporin A on the morphology and tegumentary ultrastructure of Hymenolepis microstoma in vivo. Parasitology 104, 531–8.CrossRefGoogle ScholarPubMed
Webster, L. M. & Thomson, A. W. (1987). Cyclosporin A prevents suppression of delayed-type hypersensitivity in mice immunized with high dose sheep erythrocytes. Immunology 60, 409–14.Google ScholarPubMed
White, T. R., Thompson, R. C. A. & Penhale, W. J. (1983). The effects of selective immunosuppression on resistance of Mesocestoides corti in strains of mice showing high and low initial susceptibility. Zeitschrift für Parasitenkunde 69, 91–104.CrossRefGoogle ScholarPubMed
White, T. R., Thompson, R. C. A., Penhale, W. J. & Chihara, G. (1988). The effect of lentinan on the resistance of mice to Mesocestoides corti. Parasitology Research 74, 563–8.CrossRefGoogle ScholarPubMed
Wyler, D. J., Beller, B. I. & Sypek, J. P. (1987). Macrophage activation for antileishmanial defense by an apparently novel mechanism. Journal of Immunology 138, 1246–9.CrossRefGoogle ScholarPubMed
Zahner, H. & Schultheiss, K. (1987). Effect of cyclosporin A and some derivatives in Litomosoides carinii-infected Mastomys natalensis. Journal of Helminthology 61, 282–90.CrossRefGoogle ScholarPubMed